A new name

AstraZeneca has officially changed the name of its COVID-19 vaccine AstraZeneca has now registered the brand name Vaxzevria for its COVID-19 vaccine. The TGA approved the name change on Thursday for the product previously named COVID-19 Vaccine AstraZeneca. It is estimated that supply in Australia of the Vaxzevria-branded product will commence in late 2021. Once supply of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Losartan and irbesartan with ‘unacceptable levels’ of impurity
Next ‘They can be executed:’ anti-vaxxer threatens pharmacists